Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 24023356)

1.

Aberrant expression of CXCR4 and β-catenin in pancreatic cancer.

Wang Z, Ma Q, Li P, Sha H, Li X, Xu J.

Anticancer Res. 2013 Sep;33(9):4103-10.

PMID:
24023356
2.

Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.

Wang Z, Ma Q.

Med Hypotheses. 2007;69(4):816-20. Epub 2007 Mar 26.

PMID:
17379424
3.

Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.

Wang J, Cai J, Han F, Yang C, Tong Q, Cao T, Wu L, Wang Z.

Int J Gynecol Cancer. 2011 Aug;21(6):981-7. doi: 10.1097/IGC.0b013e31821d2543.

PMID:
21738044
4.

Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M.

Clin Cancer Res. 2000 Sep;6(9):3530-5.

5.

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway.

Wang Z, Ma Q, Liu Q, Yu H, Zhao L, Shen S, Yao J.

Br J Cancer. 2008 Nov 18;99(10):1695-703. doi: 10.1038/sj.bjc.6604745. Epub 2008 Oct 28.

6.

Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.

Yasuoka H, Kodama R, Tsujimoto M, Yoshidome K, Akamatsu H, Nakahara M, Inagaki M, Sanke T, Nakamura Y.

BMC Cancer. 2009 Jul 7;9:220. doi: 10.1186/1471-2407-9-220.

7.

CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.

Saur D, Seidler B, Schneider G, Algül H, Beck R, Senekowitsch-Schmidtke R, Schwaiger M, Schmid RM.

Gastroenterology. 2005 Oct;129(4):1237-50.

PMID:
16230077
8.

Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.

Cui J, Xi H, Cai A, Bian S, Wei B, Chen L.

Int J Mol Med. 2014 Jul;34(1):197-204. doi: 10.3892/ijmm.2014.1759. Epub 2014 Apr 25.

PMID:
24788044
9.

Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.

Ramos EA, Grochoski M, Braun-Prado K, Seniski GG, Cavalli IJ, Ribeiro EM, Camargo AA, Costa FF, Klassen G.

PLoS One. 2011;6(12):e29461. doi: 10.1371/journal.pone.0029461. Epub 2011 Dec 29.

10.

Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.

Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ.

Med Oncol. 2012 Mar;29(1):151-60. doi: 10.1007/s12032-010-9816-5. Epub 2011 Jan 23.

PMID:
21259057
11.

Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.

Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L, Fan S.

Hum Pathol. 2013 Jul;44(7):1357-64. doi: 10.1016/j.humpath.2012.10.025. Epub 2013 Jan 31.

PMID:
23375645
13.

Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.

Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Kodama R, Sanke T, Nakamura Y.

BMC Cancer. 2008 Nov 23;8:340. doi: 10.1186/1471-2407-8-340.

14.

The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.

Lu CL, Ji Y, Ge D, Guo J, Ding JY.

Dis Esophagus. 2011 May;24(4):283-90. doi: 10.1111/j.1442-2050.2010.01135.x. Epub 2010 Nov 18.

PMID:
21087342
15.

[Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].

Liu FF, Wei J, Lang RG, Fan Y, Cui LF, Gu F, Fu L.

Zhonghua Bing Li Xue Za Zhi. 2008 Aug;37(8):529-35. Chinese.

PMID:
19094464
16.

SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.

Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo H, Tian T, Ruan ZP, Kang XM, Wang J, Wang SH, Nan KJ.

Cancer Lett. 2014 Nov 28;354(2):417-26. doi: 10.1016/j.canlet.2014.08.012. Epub 2014 Aug 20.

PMID:
25150783
17.

The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.

Cui K, Zhao W, Wang C, Wang A, Zhang B, Zhou W, Yu J, Sun Z, Li S.

J Surg Res. 2011 Nov;171(1):143-50. doi: 10.1016/j.jss.2010.03.001. Epub 2010 Mar 26.

PMID:
20462600
18.

Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.

Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY.

Int J Oncol. 2009 Feb;34(2):473-80.

PMID:
19148483
19.

Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis.

Gao Z, Wang X, Wu K, Zhao Y, Hu G.

Pancreatology. 2010;10(2-3):186-93. doi: 10.1159/000236012. Epub 2010 May 17.

PMID:
20484957
20.

Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.

He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, Liu F, Qin X, Sun Y.

PLoS One. 2013 Aug 6;8(8):e71864. doi: 10.1371/journal.pone.0071864. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk